WEBINAR: The Future of Precision Medicine Drug Discovery, Clinical Trials, & Diagnostics


Without validated biomarkers or an understanding of the molecular cause of disease, diagnosis of complex chronic conditions such as Long COVID and ME/CFS often takes years with multiple misdiagnoses and ineffective treatment plans leaving patients without effective therapies.

In this webinar, PrecisionLife and Metrodora Institute will share a first-of-its-kind approach which aims to rapidly develop and clinically validate new diagnostics and personalized treatments for a range of diseases to accelerate the diagnosis and treatment of complex chronic conditions and improve outcomes both for biopharma R&D and patients. 

 

Register your interest

Register your interest

The Future of Precision Medicine Drug Discovery, Clinical Trials, & Diagnostics

In this webinar you’ll learn about:

  • Precision medicine for complex, chronic diseases including Long COVID, ME/CFS, ALS, Endometriosis, and many more
  • New class of diagnostics that provide an accurate view of disease risk and effective therapies based on a patient's disease biology
  • Rapid precision medicine clinical trials leveraging complementary diagnostics to maximize success in drug discovery & development
PrecisionLife Metrodora webinar speakers 2-min

Register your interest here
"PrecisionLife's unrivaled understanding of the mechanistic causes of disease enables us to better diagnose individual patients and specify which therapies are most likely to be effective in treating them.”
John Wirthlin, CEO of Metrodora Institute